6th May 2015 07:42
LONDON (Alliance News) - GW Pharmaceuticals PLC said Wednesday that it raised USD179.2 million in its offering of 1.6 million American Depositary Shares at USD112.00 each.
It has granted the underwriters a 30 day option to buy up to an additional 240,000 American Depositary Shares at the offering price less the underwriting discount.
Morgan Stanley, Bank of America Merrill Lynch, and Cowen and Company acted as joint book0running managers for the offering. Piper Jaffray & Co acted as lead manager.
Shares in GW Pharmaceuticals are trading down 1.4% at 588.25 pence Wednesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
GWP.L